Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
David Joshua Bartch Insider Profile
4 Followers
David Joshua Bartch, Chief Executive Officer at Mydecine Innovations Group, holds 1.48M shares in Mydecine Innovations Group (Ticker: TSE:MYCO). Most recently, David Joshua Bartch Bought C$600,000 shares of Mydecine Innovations Group on Jan 12, 2024 for an estimated value of 18.48K.
David Joshua Bartch Mydecine Innovations Group (MYCO)Chief Executive Officer
Mydecine Innovations Group (MYCO)
Chief Executive Officer
Ranked #49,498 out of 100,202 Corporate Insiders
Profitable Transactions
0 out of 7 Profitable Transactions
Average Return
0.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of David Joshua Bartch's holdings
Insider Roles
Chief Executive Officer
Roles that David Joshua Bartch holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Sep 15, 2022 - Sep 15, 2023
Return:0.00%
The most profitable trade made by David Joshua Bartch
David Joshua Bartch's Trading History
List of latest transactions for each holding click on a transaction to see David Joshua Bartch's performance on stock
You May Also Like
David Joshua Bartch insider profile FAQ
What is the percentage of profitable transactions made by David Joshua Bartch?
The percentage of profitable transactions made by David Joshua Bartch is 0%.
What is the average return per transaction made by David Joshua Bartch?
The average return per transaction made by David Joshua Bartch is 0.00%.
What stocks does David Joshua Bartch hold?
David Joshua Bartch holds: TSE:MYCO stocks.
What was David Joshua Bartch’s latest transaction?
David Joshua Bartch latest transaction was an Informative Buy of C$18.48K.
What was David Joshua Bartch's most profitable transaction?
David Joshua Bartch’s most profitable transaction was an Informative Buy of TSE:MYCO stock on September 15, 2022. The return on the trade was 0.00%.
What is David Joshua Bartch's role in Mydecine Innovations Group?
David Joshua Bartch's role in Mydecine Innovations Group is Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.